Physiologic MR Imaging of Salivary Gland Tumors
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study ID
- NCT04452162
- Status
- Recruiting
Conditions
- Salivary Gland Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MRI — DIAGNOSTIC_TESTYou are being asked to complete one research MRI scan with and without contrast since your most recent clinical evaluation and/or prior imaging has shown the presence of a suspicious salivary gland tumor, prior to your scheduled upcoming surgery. MRI contrast agents act like a dye to make MRI pictures brighter and easier to read. During each MRI scan, you will have an intravenous line (IV line) placed. The IV line allows the contrast agent to be injected into your vein. If you have a history of renal disease you may be asked to complete a blood draw of approximately 2.5cc (½ teaspoon), for glomerular filtration rate (GFR) assessment for participation into the study.
Study Details
The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.
Key Dates
- Start date
- Aug 25, 2020
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Salivary Gland Tumor
Primary Outcome Measure
Differentiation and Progression Free [ Time Frame: 6 Month after the end of treatment ]
Central Contacts
- Marisa Sanchez2159019994
- Lisa Desiderio610-721-3365
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Marisa Sanchez Sanjeev Chawla (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
By research site
Related Studies
- A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursPHASE1 · Recruiting · Avacta Life Sciences Ltd · New York, New York